Skip to main content

Sight Sciences, Inc.

SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531177

In the last 90 days, Sight Sciences, Inc. insiders filed 0 open-market purchases and 6 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Sight Sciences, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of SGHT: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7780+3
Shares20.7M21.1M+348.0K (+1.7%)
Value$49.6M$86.4M+$36.9M (+74.4%)

New holders (13)

Institutions that held Sight Sciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to SGHT in Q2 2025
InstitutionSharesValue% of portfolio
Americana Partners, LLC863,918$3.57M0.12%
Apeiron RIA LLC83,376$344.3K0.09%
Palumbo Wealth Management LLC79,404$327.9K0.10%
Jane Street Group, LLC35,739$147.6K0.00%
Panagora Asset Management Inc31,919$131.8K0.00%
MetLife Investment Management27,037$111.7K0.00%
Verition Fund Management LLC20,009$82.6K0.00%
XTX Topco Ltd16,212$67.0K0.00%
Bank of Montreal11,755$48.5K0.00%
Ieq Capital, LLC11,018$45.5K0.00%
Fortitude Family Office, LLC175$7230.00%
Essential Partners LLC95$3920.00%
IFP Advisors, Inc0$170.00%

Sold out (10)

Institutions that held Sight Sciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.